Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Applying geospatial methods in leprosy prevention and control

Taal A. Erasmus University Rotterdam. Erasmus University Rotterdam. 2023;
Download PDF
Publication

Nerve Calcification Caused by Leprosy in Northern Territory Aboriginals

Bateson EM, Hargrave JC. AMPCo. Medical Journal of Australia. 1979; 2 (9) : 497-499.
Download PDF
Practical material

What are the challenges that women affected by leprosy face?

The Leprosy Mission International . 2024;
Access resource
Publication

Fontilles 120 years ago: the last sanatorium in Europe

Jover I A. La Marina Alta. 2024;
Download PDF
Publication

Leprosy Reactions: Unraveling Immunological Mechanisms Underlying Tissue Damage in Leprosy Patients.

Serrano-Coll H, Wan E, Restrepo-Rivera L, et al. Pathogens and disease. 2024;
Download PDF
Publication

Occurence of Leprosy Cases in Amazonas in a 5-Year Retrospective Period

Portela de Azevedo A, Merlo Rosell JA, Almeida Paulain B. Editora RECIMA21 LTDA. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218. 2024; 5 (5) : 1-8.
Download PDF
Publication

A Study of Quantitative Correlations Between Crucial Bio-markers and the Optimal Drug Regimen of Type-I Lepra Reaction

Ramanjaneyulu C, Nayak D, Vamsi D. Cornell University. 2024;
Download PDF
Publication

Amelanotic melanoma with neural lesion simulating leprosy

Westin AT, Barros Junior SAD, Souza CDS. Elsevier BV. Anais Brasileiros de Dermatologia. 2024;
Download PDF
Publication

Lepra lepromatosa multibacilar detectada en el cantón Olmedo, Ecuador. Reporte de caso

Alejandro Polanco CR, Rivadeneira Lucas MA, Loor Vinces LW, et al. Salud, Ciencia y Tecnologia. Salud, Ciencia y Tecnología. 2024;
Download PDF
Publication

Neurologic Complications of Leprosy: A Case Series

Benlamkadam S, Raymond K, Chraa M, et al. Springer Science and Business Media LLC. Cureus. 2024;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 94
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD